BPA CALL
ExpiredHT941026FE065
Department of Defense › Defense Health Agency › DEFENSE HEALTH AGENCY HCD WEST
$167.3K
obligated · signed 4 months ago
PLUVICTO AND LUTATHERA INJECTIONS
Performance timeline
Start
Jun 3, 2026
End
Sep 30, 2026
with all options
Loading status
This contract has expired. A follow-on may have been awarded.
Search for new solicitations from Department of Defense.
NOVARTIS PHARMACEUTICALS CORPORATION
Contract HT941026FE065
UEI
NG61ZA8TADW3
Parent Company
NOVARTIS SANIERUNGSSTIFTUNG
Capabilities & Certifications
Headquarters Location
Congressional District: 11
Current Obligation
$167,285
Base + Exercised Options
$167,285
Total Ceiling Value
$167,285
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 11
Awarding Agency
Top-tier agency
Defense Health Agency
Sub-tier agency
DEFENSE HEALTH AGENCY HCD WEST
Office
Funding Agency
Top-tier agency
Defense Health Agency
Sub-tier agency
NAV MED CTR SAN DIEGO CA - MM
Office
Contract Vehicle
HT941026AE002
BPADepartment of Defense
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.